Finance

Lists
603676:SHA
Xizang Weixinkang Pharmaceutical Co Ltd
8,77 CN¥
-0,68%
(-0,060) 1D
16 հոկ, 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603676...
Open
8,96 CN¥
High
9,06 CN¥
Low
8,72 CN¥
Mkt. cap
3,82 մլրդ
Avg. vol.
1,57 մլն
Volume
1,84 մլն
Dividend
3,73%
Quarterly dividend
0,08 CN¥
Ex-dividend date
29 հնս, 2026 թ.
P/E ratio
19,68
52-wk high
12,08 CN¥
52-wk low
7,82 CN¥
EPS
0,45 CN¥
Shares outstanding
423,00 մլն
No. of employees
763
Open
8,96 CN¥
High
9,06 CN¥
Low
8,72 CN¥
Mkt. cap
3,82 մլրդ
Avg. vol.
1,57 մլն
Volume
1,84 մլն
Dividend
3,73%
Quarterly dividend
0,08 CN¥
Ex-dividend date
29 հնս, 2026 թ.
P/E ratio
19,68
52-wk high
12,08 CN¥
52-wk low
7,82 CN¥
EPS
0,45 CN¥
Shares outstanding
423,00 մլն
No. of employees
763
News stories
From web sources and news partners
About Xizang Weixinkang Pharmaceutical Co Ltd
CEO-
Employees763
Founded2002
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
276,24 մլն
273,33 մլն
322,14 մլն
262,14 մլն
Cost of goods sold
103,31 մլն
113,44 մլն
128,24 մլն
109,51 մլն
Cost of revenue
103,31 մլն
113,44 մլն
128,24 մլն
109,51 մլն
Research and development expenses
28,10 մլն
34,04 մլն
19,29 մլն
20,63 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
85,75 մլն
111,67 մլն
93,39 մլն
87,12 մլն
Operating expense
81,29 մլն
180,88 մլն
116,61 մլն
110,23 մլն
Total operating expenses
184,60 մլն
294,32 մլն
244,85 մլն
219,74 մլն
Operating income
91,65 մլն
-20,98 մլն
77,29 մլն
42,40 մլն
Other non operating income
10,90 հզր
-224,74 հզր
7,57 հզր
-160,84 հզր
EBT including unusual items
60,67 մլն
15,41 մլն
80,30 մլն
86,94 մլն
EBT excluding unusual items
95,80 մլն
-17,48 մլն
80,14 մլն
45,64 մլն
Income tax expense
24,28 մլն
1,73 մլն
11,96 մլն
12,35 մլն
Effective tax rate
40,02%
11,24%
14,89%
14,21%
Other operating expenses
-32,87 մլն
36,84 մլն
3,07 մլն
2,08 մլն
Net income
36,39 մլն
13,68 մլն
68,34 մլն
74,59 մլն
Net profit margin
13,17%
5,00%
21,21%
28,45%
Earnings per share
-
-
-
-
Interest and investment income
4,35 մլն
3,80 մլն
2,94 մլն
3,44 մլն
Interest expense
-84,28 հզր
-58,13 հզր
-98,46 հզր
-53,47 հզր
Net interest expenses
4,27 մլն
3,74 մլն
2,84 մլն
3,39 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
103,26 մլն
-10,17 մլն
88,10 մլն
53,19 մլն
Gain or loss from assets sale
88,96 հզր
80,57 հզր
-
4,48 հզր
AI content may include mistakes. Learn more
Google Apps